Lund, Sweden – 16 July 2018 — Camurus (NASDAQ STO: CAMX) announced today that the US Food and Drug Administration (FDA) assigned a Prescription Drug User Fee Act (PDUFA) goal date of December 26, 2018 for its investigational weekly and monthly…Original Article
Camurus Announces PDUFA Date for CAM2038 for the Treatment of Opioid Use Disorder
